Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Deloitte
AstraZeneca
Dow
Cerilliant
Cantor Fitzgerald
Healthtrust
Chubb
Moodys

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,150,366

« Back to Dashboard

Which drugs does patent 6,150,366 protect, and when does it expire?

Patent 6,150,366 protects GEODON and is included in two NDAs.

This patent has fifty-six patent family members in forty-three countries.
Summary for Patent: 6,150,366
Title: Ziprasidone formulations
Abstract:Compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles having a mean particle size less than 85 .mu.m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to treat psychoses such as schizophrenia.
Inventor(s): Arenson; Daniel R. (East Lyme, CT), Busch; Frank Robert (Gales Ferry, CT), Hausberger; Angela G. (East Lyme, CT), Rasadi; Bijan (Groton, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/320,985
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Device; Use; Process;

Drugs Protected by US Patent 6,150,366

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-001 Feb 5, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-002 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-003 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Pfizer GEODON ziprasidone hydrochloride CAPSULE;ORAL 020825-004 Feb 5, 2001 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Argus Health
Express Scripts
Accenture
US Department of Justice
Johnson and Johnson
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.